粒子複合化装置メカノフュージョンを用いた粉末吸入インスリン製剤用PLGAナノコンポジット粒子の設計

書誌事項

タイトル別名
  • Poly (lactic-co-glycolic acid) Nanosphere Composite Prepared with Mechanofusion<sup>®</sup> Dry Powder Composition System for Improving Pulmonary Insulin Delivery with Dry Powder Inhalation

この論文をさがす

抄録

<p>To develop an effective dry-powder inhalation system for insulin absorption, via the alveoli, a nanocomposite particle system was prepared using the Mechanofusion® dry-powder composition system. The nanocomposite particles were an ordered mixture of coarse carrier lactose (c.a. 60 μm in diameter) adsorbed with poly (lactic-co-glycolic acid) (PLGA) nanospheres (c.a. 250nm in diameter). The flowability and in vitro inhalation property of the resultant PLGA composite was improved as compared to untreated PLGA nanosphere powder. The inhalation properties of the PLGA nanosphere composite were determined by the Mechanofusion® operating conditions. Slow speed operation (270 rpm) of the composing rotor could not combine the PLGA nanospheres with lactose. A rotor speed higher than 370 rpm was required to enable proper composition. However, applying a high share force during for composition process, (i.e., setting a narrow clearance), deteriorated the inhalation property and the redispersibility of the resultant composite particle into water to reconstruct the original nanosphere. About 65% of the intratracheally administered composite particle was deposited deeply into the lung of rat. The nanocomposite particle dry powder inhalation system using insulin loaded PLGA nanospheres significantly improved the absorption of insulin and prolonged the pharmacological action compared to insulin solutions administered intravenously or intratracheally.</p>

収録刊行物

  • 薬剤学

    薬剤学 64 (4), 245-253, 2004

    公益社団法人 日本薬剤学会

被引用文献 (6)*注記

もっと見る

参考文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ